Abstract
Drug administration customized to individual cells could intrinsically address cancer heterogeneity and provide a safe and effective method for delivering personalized treatment. To accomplish this, we developed a smart nanodrug delivery system characterized by cancer cell-targeted drug delivery and intracellular biomarker-responsive drug activation. This system was composed of a long-nicked DNA duplex formed by tandem hybridization of two extended antisense oligonucleotides whose ends were separately blocked with a cancer cell-specific aptamer, AS1411, and a replaceable anti-biomarker probe (ABP). We demonstrated that this DNA nanodrug was directed to cancer cells with the guidance power of AS1411 and then activated by the presence of a given intracellular biomarker. By using such a belt-and-braces strategy, this DNA nanodrug system could safely and efficiently accelerate apoptosis of target cancer cells. Moreover, since the expression level of biomarkers tends to indicate the specific physiological state of individual cells, biomarker-responsive activation of the nanodrug is expected to enable customized drug administration at the cellular level.
Similar content being viewed by others
References
Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, Sboner A, Esgueva R, Pflueger D, Sougnez C, Onofrio R, Carter SL, Park K, Habegger L, Ambrogio L, Fennell T, Parkin M, Saksena G, Voet D, Ramos AH, Pugh TJ, Wilkinson J, Fisher S, Winckler W, Mahan S, Ardlie K, Baldwin J, Simons JW, Kitabayashi N, MacDonald TY, Kantoff PW, Chin L, Gabriel SB, Gerstein MB, Golub TR, Meyerson M, Tewari A, Lander ES, Getz G, Rubin MA, Garraway LA. Nature, 2011, 470: 214–220
Sander C. Science, 2000, 287: 1977–1978
Almendro V, Marusyk A, Polyak K. Annu Rev Pathol Mech Dis, 2013, 8: 277–302
Niidome T, Huang L. Gene Ther, 2002, 9: 1647–1652
Stegh AH. Integr Biol, 2013, 5: 48–65
Wang L, Zhang H, Qin A, Jin Q, Tang BZ, Ji J. Sci China Chem, 2016, 59: 1609–1615
Xu C, Tian H, Chen X. Sci China Chem, 2017, 60: 319–328
Jia H, Chen S, Zhuo R, Feng J, Zhang X. Sci China Chem, 2016, 59: 1397–1404
Pinheiro AV, Han D, Shih WM, Yan H. Nat Nanotech, 2011, 6: 763–772
Fang X, Tan W. Acc Chem Res, 2009, 43: 48–57
Chang YT, Liao PY, Sheu HS, Tseng YJ, Cheng FY, Yeh CS. Adv Mater, 2012, 24: 3309–3314
Dicheva BM, ten Hagen TLM, Li L, Schipper D, Seynhaeve ALB, van Rhoon GC, Eggermont AMM, Lindner LH, Koning GA. Nano Lett, 2012, 13: 2324–2331
Lee JH, Chen KJ, Noh SH, Garcia MA, Wang H, Lin WY, Jeong H, Kong BJ, Stout DB, Cheon J, Tseng HR. Angew Chem, 2013, 125: 4480–4484
Huebsch N, Kearney CJ, Zhao X, Kim J, Cezar CA, Suo Z, Mooney DJ. Proc Natl Acad Sci USA, 2014, 111: 9762–9767
Nair M, Guduru R, Liang P, Hong J, Sagar V, Khizroev S. Nat Commun, 2013, 4: 1707
Mura S, Nicolas J, Couvreur P. Nat Mater, 2013, 12: 991–1003
Cheng R, Feng F, Meng F, Deng C, Feijen J, Zhong Z. J Control Release, 2011, 152: 2–12
Zhang X, Yang P, Dai Y, Ma P, Li X, Cheng Z, Hou Z, Kang X, Li C, Lin J. Adv Funct Mater, 2013, 23: 4067–4078
Xing L, Zheng H, Cao Y, Che S. Adv Mater, 2012, 24: 6433–6437
Chung MF, Chia WT, Wan WL, Lin YJ, Sung HW. J Am Chem Soc, 2015, 137: 12462–12465
Zhang DY, Seelig G. Nat Chem, 2011, 3: 103–113
Ireson C, Green C, Cook J, Djeha H, Ritchie C, Jones D, Kelland LR. Cancer Res, 2006, 66: 1107–1108
Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. Oncogene, 2007, 26: 2799–2803
Wang PY, Li YJ, Zhang S, Li ZL, Yue Z, Xie N, Xie SY. Mol Cell Biochem, 2010, 339: 163–171
Cheng AM, Byrom MW, Shelton J, Ford LP. Nucleic Acids Res, 2005, 33: 1290–1297
Li L, Hou J, Liu X, Guo Y, Wu Y, Zhang L, Yang Z. Biomaterials, 2014, 35: 3840–3850
Monia BP, Johnston JF, Geiger T, Muller M, Fabbro D. Nat Med, 1996, 2: 668–675
Zhu G, Zheng J, Song E, Donovan M, Zhang K, Liu C, Tan W. Proc Natl Acad Sci USA, 2013, 110: 7998–8003
Kesharwani P, Gajbhiye V, Jain NK. Biomaterials, 2012, 33: 7138–7150
Reyes-Reyes EM, Teng Y, Bates PJ. Cancer Res, 2010, 70: 8617–8629
Zhang J, Wang J, Zhao F, Liu Q, Jiang K, Yang G. Clinica Chim Acta, 2010, 411: 846–852
Cao M, Hou D, Liang H, Gong F, Wang Y, Yan X, Jiang X, Wang C, Zhang J, Zen K, Zhang CY, Chen X. Eur J Cancer, 2014, 50: 1013–1024
Acknowledgements
This work was supported by the National Natural Science Foundation of China (21505039, 2013CB932702), the China National Instrumentation Program (2011YQ03012412) and the National Institutes of Health grants (GM079359, CA133086).
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Li, J., Qiu, L., Xie, S. et al. Engineering a customized nanodrug delivery system at the cellular level for targeted cancer therapy. Sci. China Chem. 61, 497–504 (2018). https://doi.org/10.1007/s11426-017-9176-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-017-9176-3